Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.
You can purchase shares of Greenwich LifeSciences (NASDAQ:GLSI) through any online brokerage.
Other companies in Greenwich LifeSciences’s space includes: Innate Pharma (NASDAQ:IPHA), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Adaptimmune Therapeutics (NASDAQ:ADAP) and Lexeo Therapeutics (NASDAQ:LXEO).
Greenwich LifeSciences has a consensus price target of $38.00.
The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $12.6 last updated January 22, 2025 at 9:08 AM EST.
There are no upcoming dividends for Greenwich LifeSciences.
Greenwich LifeSciences’s Q4 earnings are confirmed for Monday, April 14, 2025.
There is no upcoming split for Greenwich LifeSciences.
Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.